Tofacitinib for Induction Therapy in Patients with Active Ulcerative Colitis in Two Phase 3 Clinical Trials: Results by Local and Central Endoscopic Assessments

被引：2

作者：

Feagan, Brian ^{[1
]}

Vermeire, Severine ^{[2
]}

Sandborn, William J. ^{[3
]}

Reinisch, Walter ^{[4
]}

Tarabar, Dino ^{[5
]}

Su, Chinyu ^{[6
]}

Niezychowski, Wojciech ^{[6
]}

Zhang, Haiying ^{[6
]}

Woodworth, Deborah ^{[6
]}

Yu, Dahong ^{[6
]}

Sands, Bruce ^{[7
]}

机构：

[1] Western Univ, Robarts Res Inst, London, ON, Canada

[2] Univ Hosp Leuven, Leuven, Vlaams Brabant, Belgium

[3] Univ Calif San Diego, La Jolla, CA 92093 USA

[4] Med Univ Vienna, Vienna, Austria

[5] Mil Med Acad, Belgrade, Serbia

[6] Pfizer Inc, Collegeville, PA USA

[7] Icahn Sch Med Mt Sinai, New York, NY 10029 USA

来源：

关键词：

D O I：

10.14309/00000434-201610001-00709

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

709

引用

页码：S319 / S320

页数：2